Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)	$ 321,664	$ (467,479)	$ (625,318)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	266,775	282,883	310,883
Amortization and write-off of original issue discount and deferred financing cost	22,356	38,979	22,732
Loss on extinguishment of debt	0	(28,628)	0
Amortization of content costs	23,202	584,871	38,283
Impairment charges	689	4,524	220,477
Gain on sale/disposal and impairment of assets	(832)	(7,662)	(12,471)
Gain on business divestitures	(508,439)	0	(30,999)
Equity-based compensation expense	210,163	532,467	91,271
Change in fair value of contingent liabilities	2,373	16,204	(3,671)
Change in fair value of equity investments with and without readily determinable fair value	(12,240)	(14,108)	316
Change in fair value of financial instruments	6,250	36,144	(3,486)
Equity losses from affiliates	223,604	72,733	260,094
Net (benefit) provision for allowance for doubtful accounts	(422)	(7,814)	38,542
Net loss on foreign currency transactions	20,189	4,953	9,047
Distributions from affiliates	7,433	5,786	9,405
Tax receivable agreement liability adjustment	873,264	101,736	0
Income taxes	(708,598)	(73,755)	(13,401)
Other, net	(189)	(1,343)	2,225
Changes in operating assets and liabilities - net of acquisitions:
(Increase)/decrease in receivables	(278,199)	(351,585)	313,989
Increase/decrease in other current assets	(79,563)	(90,196)	59,041
Increase in other assets	(45,130)	(800,944)	(268,918)
(Increase)/decrease in deferred costs	(20,116)	(18,108)	80,984
Increase/(decrease) in deferred revenue	55,097	115,177	(43,252)
Increase/(decrease) in accounts payable and accrued liabilities	55,003	215,794	(87,489)
Increase/(decrease) in other liabilities	68,600	125,714	(207,066)
Net cash provided by operating activities	502,934	333,599	161,218
CASH FLOWS FROM INVESTING ACTIVITIES:
Acquisitions, net of cash acquired	(1,434,515)	(436,372)	(317,929)
Purchases of property and equipment	(147,964)	(99,802)	(71,651)
Proceeds from business divestitures, net of cash sold	924,751	0	0
Proceeds from sale of assets	4,037	21,993	113,026
Investments in affiliates	(52,273)	(154,104)	(37,644)
Other, net	1,429	9,205	(1,594)
Net cash used in investing activities	(704,535)	(659,080)	(315,792)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from borrowings	15,648	1,052,703	1,218,270
Payments on borrowings	(593,712)	(1,087,393)	(568,733)
Contributions	0	5,550	0
Distributions	(36,386)	(9,175)	(123,173)
Redemption payments related to pre-IPO units	(9,412)	(40,320)	(53,856)
Exercise of stock options	0	458	0
Proceeds from equity offering, net of underwriting discounts and offerring expenses	0	1,886,643	0
Acquisition of non-controlling interests	92,487	(835,683)	0
Payments of contingent and deferred consideration related to acquisitions	(18,107)	(2,219)	(2,320)
Other, net	(427)	(10,389)	(16,199)
Net cash (used in) provided by financing activities	(549,909)	960,175	453,989
Change in cash, cash equivalents and restricted cash balances held for sale	24,599	(28,736)	0
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(20,132)	(3,255)	4,845
(Decrease) increase in cash, cash equivalents and restricted cash	(747,043)	602,703	304,260
Cash, cash equivalents and restricted cash at beginning of year	1,793,036	1,190,333	886,073
Cash, cash equivalents and restricted cash at end of year	$ 1,045,993	$ 1,793,036	$ 1,190,333